Novel epilepsy treatment

Details Novel epilepsy treatment Novel epilepsy treatment

A - Human Necessities

61

K

A61K 31/439 (2006.01) A61K 31/46 (2006.01) A61P 25/08 (2006.01)

Patent

CA 2616141

The present invention resides in the use of a 5-HT3 receptor antagonist as medicament for the treatment of temporal lobe epilepsy associated with hippocampal sclerosis (TLE-HS) in a human patient. Tropisetron or Dolasetro are the preferred compounds .

La présente invention concerne l~utilisation d~un antagoniste des récepteurs 5-HT3 en tant que médicament pour le traitement de l~épilepsie temporale associée à une sclérose hippocampique (TLE-HS) chez un patient humain. Les composés préférés dans le cadre de cette invention sont le tropisétron ou le dolasetro.

Affiliated with

Also associated with

Rating

Novel epilepsy treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel epilepsy treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel epilepsy treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1875938